THE TAPE

RLI Corp.

$70.95▲ +1.87%
Last close
Relative strength
75RS
of 99, against every stock▲ +29 on the month
Powering up
Front line
+14.8%
six months against Fire, Marine & Casualty Insurance
52-week range
−1.3%
from the high
$47.26$71.89
Setup
multi yearforming
−8.1%
against the pivot at $77.24
No report date on the calendar.
Growth WEAKProof SHOWN
Quarter to Sep 30, revenue −6% on a year ago
11/16 O 70.89 H 71.03 L 70.08 Vol 592.6K
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

All four are in order, fastest above slowest — every timeframe pointing the same way.

RS75
vs pivot−8.14%
Tightening0.75×
Dry-up0.83×
Up/down vol0.20
From high1%
forming5 of 9checks
Powering up
Support and resistance
Support below
$67.07
-5.5% · tested 4× · last 5 sessions ago
Resistance above
None within the last 120 sessions

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 73.6 weeks and fell 39% from its ceiling at its deepest. The pivot is $77.24, and the stock closed 8.1% below it. Its relative strength rating is 75.

Against its industry
Front lineAhead of its industry over one, three and six months, in an industry fully aligned and ahead of the S&P 500.
One month against its industry
+11.7%
Three months against its industry
+3.5%
Six months against its industry
+14.8%

Read against an equal-weighted index of Fire, Marine & Casualty Insurance, which is +16.5% against the S&P 500 over six months Fully aligned.

Also on
Peers
Same theme
No themes — common and fine.
Catalyst roadmap
14
days
Ex-dividend in 14 days
Nov 30, 2026 · 1 more dated below
  1. Ex-dividendconfirmedin 14d
    Ex-dividend date
    Nov 30, 2026
  2. Ex-dividendconfirmedin 14d
    Ex-dividend date
    Nov 30, 2026
How it moves on earnings

On average 3.7% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$1.9B
-6.3% year on year
Operating margin
—
Net margin
20.3%
Free cash flow
$531.5M
8.2% of market cap
Price to sales
3.35×
Price to earnings
16.5×

Twelve months to Sep 30, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Oct 19
Key takeaway
Revenue is falling but the business still generates cash.
Revenue
$477.0M
-17.1% QoQ · -6.3% YoY
Gross margin
—
Net income
$81.0M
Positive
Free cash flow
$192.4M
Cash generating

What the numbers say

  • Weak: Revenue -6.3% year over year, -17.1% on the quarter
  • Good: Profitable: net income $81M
  • Good: Cash generating: operating cash flow $195M, free cash flow $192M
  • Net debt $251M · cash $46M
Revenue by quarter
Free cash flow
Net income
shares -0.1% in a year · net debt $250.8M
Final read
Growth: WEAK · Economic proof: SHOWN
Key question: Can the cash generation hold as growth slows?
The next test is revenue growth: revenue -6.3% year over year, -17.1% on the quarter.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

Held by 1 of 46 tracked funds at the end of Q3 2026.

Last quarter: 1 trimmed.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
Tightening after a sharp runTape · 2026-10-31
range halved after a +19% thrust, at 65.23
No measurable effect: stocks behave like random ones over the next three sessions (887 cases over 60 nights).
Reported resultsFiling · 2026-10-20
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
Earnings date movedEvent · 2026-10-07
2026-10-26 -> 2026-10-19
No measurable effect: stocks behave like random ones over the next three sessions (2,989 cases over 51 nights).
Unusual volumeTape · 2026-09-19
6.3 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders
Bought on the open market
5
$752,115 total
Sold on the open market
0

Bought: KELLOGG CLARK C, Duclos David B., Kliethermes Craig W, Klobnak Jennifer L.

Most recent filings
2026-06-01 KELLOGG CLARK C · Directorbuy3,000$152,700
2026-05-28 Duclos David B. · Directorbuy2,500$129,975
2026-05-27 Kliethermes Craig W · CHIEF EXECUTIVE OFFICERbuy2,000$104,000
2026-05-27 Klobnak Jennifer L · CHIEF OPERATING OFFICERbuy2,000$105,440
2026-05-21 Kliethermes Craig W · CHIEF EXECUTIVE OFFICERbuy5,000$260,000

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

The geometry
Level · floor$65.80
Wrong above$72.41
Measured target · the shape's own height$56.41
Reward against risk1.4×
Lines closed · of the gap they started with13%
Through to the apex57%
Touches · swing points the lines are drawn through6 up · 5 down
Length12.2 weeks
What lines up

5 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
Range tightening through the base
Volume drying up through the base
More up-volume than down-volume
Within 15% of its 52-week high
What analysts expect
Strong buy1
Buy0
Hold5
Sell2
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

Checking your subscription…

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
RLI Corp. (RLI) — The Tape